3 Biotech Stocks with Potential Upside: Inovio Pharmaceuticals, Dynavax, and Ariad
Inovio, Dynavax, and Ariad are three biotech stocks that deserve a second look this year. Here’s why.
Here's Why Geron Has Been So Volatile This Year
Geron's stock has been on a rollercoaster ride in 2014. Here's why.
3 Ways Ariad Pharmaceuticals Can Salvage Iclusig
Iclusig has taken quite a few knocks since October, but there are three ways Ariad could rebuild the brand's value and boost shareholder value in the process.